# Ganciclovir Pharmacokinetics in Patients Undergoing Continuous Renal Replacement Therapy

> **NCT00264368** · PHASE4 · TERMINATED · sponsor: **University of Oslo School of Pharmacy** · enrollment: 6 (estimated)

## Conditions studied

- Acute Renal Failure
- Cytomegalovirus Infections
- Multi Organ Failure

## Interventions

- **DRUG:** intravenous (IV) ganciclovir

## Key facts

- **NCT ID:** NCT00264368
- **Lead sponsor:** University of Oslo School of Pharmacy
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-12
- **Primary completion:** —
- **Final completion:** 2007-06
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2007-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00264368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00264368, "Ganciclovir Pharmacokinetics in Patients Undergoing Continuous Renal Replacement Therapy". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00264368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*